article thumbnail

Pfizer Stops Work on Oral GLP-1 Obesity Drug After Safety Signal Surfaces in Clinical Trial

MedCity News

Pfizer said a patient dosed with danuglipron developed potential drug-induced liver injury. Pfizer is stopping further work on this program, a move that comes nearly two years after it discontinued development of a different obesity drug due to liver safety signals in a clinical trial.

Safety 237
article thumbnail

Patient Safety Structural Measure Marks Progress Towards Safer and Compassionate Care

MedCity News

CMS recently finalized the Patient Safety Structural Measure, which sets forth a broad roadmap for the implementation of a culture of safety, learning, transparency and accountability within hospitals and health systems nationwide — enabling and encouraging significant progress towards safer care and improved support for healthcare workers.

Safety 290
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

4 Steps Needed to Improve Patient Safety On a National Level, Per PCAST

MedCity News

The President’s Council of Advisors on Science and Technology (PCAST) issued a report that laid out four recommendations to improve patient safety across the nation. Some of these included creating federal leadership positions focused on advancing patient safety and hastening research on systems of safe care.

Safety 289
article thumbnail

Staff Safety is Key to Sustaining Home Health Growth

MedCity News

Innovative approaches to home care will only be successful if organizations can ensure the safety of the professionals who enter patient homes. The post Staff Safety is Key to Sustaining Home Health Growth appeared first on MedCity News.

Safety 298
article thumbnail

How Machine Learning Drives Clinical Trial Efficiency

Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.

article thumbnail

'It was a good lesson': FDA reconsiders CAR-T boxed warning on secondary cancers, Peter Marks says

Fierce Pharma

An FDA announcement last year of an investigation into the risk of patients developing secondary cancers following the treatment of CAR-T cell therapies sent shock waves across the industry. | said in an interview with Fierce Pharma.

FDA 284
article thumbnail

The Value-based Care Throughline to Healthcare Quality and Safety

MedCity News

By prioritizing continuous patient engagement and strategic communication across the entire care journey, healthcare organizations can drive real progress toward value-based care. The post The Value-based Care Throughline to Healthcare Quality and Safety appeared first on MedCity News.

Safety 312